Document:

Exhibit 10.6

 

WARRANT

TO
PURCHASE SHARES OF COMMON STOCK

 

KEY LINK ASSETS CORP.

A Delaware Corporation

 

THIS WARRANT
HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE PURCHASED PURSUANT TO THE EXERCISE OF THIS WARRANT (THE “WARRANT SHARES”)
WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION THEREOF. NEITHER
THIS WARRANT NOR THE WARRANT SHARES (TOGETHER, THE “SECURITIES”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY AND ITS COUNSEL
THAT SUCH DISPOSITION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT AND OF ANY APPLICABLE
STATE SECURITIES LAWS. THIS WARRANT MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE,
PLEDGE OR OTHER TRANSFER OF ANY INTEREST IN ANY OF THE SHARES REPRESENTED BY THIS WARRANT.

 

 

	Warrant No.:	May  , 2016
	Denver, Colorado	 

 

THIS CERTIFIES THAT,
effective as of May , 2016, for U.S. Dollars ($ ) and other good and valuable consideration the receipt of which the Company hereby
acknowledges, Zhuge Liang, LLC, a Delaware limited liability company (the “Holder”), is entitled to subscribe for and
purchase from Key Link Assets Corp., a Delaware corporation (the “Company”), ( ,000) shares of the Company's Common
Stock (as adjusted pursuant to Section 2 hereof) (the “Warrant Shares”) at the purchase price of ($ ) per share (as
adjusted pursuant to Section 2 hereof) (the “Exercise Price”) , upon the terms and subject to the conditions hereinafter
set forth.

 

    	 	 	 

     

    

  

		1.	Exercise Rights.

 

(a)Cash
Exercise. The purchase rights represented by this Warrant may be exercised by the Holder at any time during the term hereof,
in whole or in part commencing on June , 2017, by surrender of this Warrant and delivery of a completed and duly executed Notice
of Cash Exercise, in the form attached as Exhibit A hereto, accompanied by payment to the Company of an amount equal to
the Exercise Price then in effect multiplied by the number of Warrant Shares to be purchased by the Holder in connection with such
cash exercise of this Warrant, which amount may be paid, at the election of the Holder, by wire transfer, delivery of a check payable
to the order of the Company or delivery of a promissory note made by the Company for whole or partial cancellation, or any combination
of the foregoing, to the principal offices of the Company. The exercise of this Warrant shall be deemed to have been effected on
the day on which the Holder surrenders this Warrant to the Company and satisfies all of the requirements of this Section. Upon
such exercise, the Holder will be deemed a shareholder of record of those Warrant Shares for which the Warrant has been exercised
with all rights of a shareholder (including, without limitation, all voting rights with respect to such Warrant Shares and all
rights to receive any dividends with respect to such Warrant Shares). If this Warrant is to be exercised in respect of less than
all of the Warrant Shares covered hereby, the Holder shall be entitled to receive a new warrant covering the number of Warrant
Shares in respect of which this Warrant shall not have been exercised and for which it remains subject to exercise. Such new warrant
shall be in all other respects identical to this Warrant.

 

(b)Cashless
Exercise.

 

(i)          In
lieu of exercising the purchase rights represented by this Warrant on a cash basis pursuant to Section 1(a) hereof, the Holder
may elect to exercise such rights represented by this Warrant at any time during the term hereof, in whole or in part, on a cashless
basis by electing to receive the number of Warrant Shares which are equal in value to the value of this Warrant (or any portion
thereof to be canceled in connection with such cashless exercise) at the time of any such cashless exercise, by delivery to the
principal offices of the Company this Warrant and a completed and duly executed Notice of Cashless Exercise, in the form attached
as Exhibit B hereto, properly marked to indicate (A) the number of Warrant Shares to be delivered to the Holder in connection
with such cashless exercise, (B) the number of Warrant Shares with respect to which the Warrant is being surrendered in payment
of the aggregate Exercise Price for the Warrant Shares to be delivered to the Holder in connection with such cashless exercise,
and (C) the number of Warrant Shares which remain subject to the Warrant after such cashless exercise, if any (each as determined
in accordance with Section 1(b)(ii) hereof).

 

(ii)         In
the event that the Holder shall elect to exercise the rights represented by this Warrant in whole or in part on a cashless basis
pursuant to this Section 1(b), the Company shall issue to the Holder the number of Warrant Shares determined in accordance with
the following formula:

 

X = Y (A-B)

A

 

	 	X	=	the number of Warrant Shares to be issued to the Holder in connection with such cashless exercise.

 

	 	Y	=	the number of Warrant Shares subject to this Warrant.

 

    	 	-2-	 

     

    

  

	 	A	=	the Fair Market Value (as defined below) of one share of common stock of the Company on the date of exercise.
	 	 	 	 
	 	B	=	the Exercise Price in effect as of the date of such cashless exercise (as adjusted pursuant to Section 2 hereof).

 

(c)Additional
Conditions to Exercise of Warrant. Unless there is a registration statement declared or ordered effective by the Securities
and Exchange Commission (the “Commission”) under the Securities Act which includes the Warrant Shares to be issued
upon the exercise of the rights represented by this Warrant, such rights may not be exercised unless and until:

 

(i)          each
certificate evidencing the Warrant Shares to be issued upon the exercise of the rights represented by this Warrant shall be stamped
or imprinted with a legend substantially in the following form:

 

THE SHARES
REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT FOR DISTRIBUTION, AND HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS. SUCH SHARES MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF
COUNSEL SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT. THIS CERTIFICATE
MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, PLEDGE OR OTHER TRANSFER OF ANY
INTEREST IN ANY OF THE SHARES REPRESENTED BY THIS CERTIFICATE.

 

(d)Fractional
Shares. Upon the exercise of the rights represented by this Warrant, the Company shall not be obligated to issue fractional
shares of Common Stock, and in lieu thereof, the Company shall pay to the Holder an amount in cash equal to the Fair Market Value
per share of Common Stock immediately prior to such exercise multiplied by such fraction (rounded to the nearest cent).

 

(e)Expiration
of Warrant. This Warrant shall expire at 5:00 p.m. Pacific Standard Time on June , 2021, and shall thereafter no longer
be exercisable or have any value whatever.

 

    	 	-3-	 

     

    

 

(f)Record
Ownership of Warrant Shares. The Warrant Shares shall be deemed to have been issued, and the person in whose name any certificate
representing Warrant Shares shall be issuable upon the exercise of the rights represented by this Warrant (as indicated in the
appropriate Notice of Exercise) shall be deemed to have become the holder of record of (and shall be treated for all purposes as
the record holder of) the Warrant Shares represented thereby, immediately prior to the close of business on the date or dates upon
which the rights represented by this Warrant are exercised in accordance with the terms hereof.

 

(g)Stock
Certificates. In the event of any exercise of the rights represented by this Warrant, certificates for the Warrant Shares
so purchased pursuant hereto shall be delivered to the Holder promptly and, unless this Warrant has been fully exercised or has
expired, a new Warrant representing the Warrant Shares with respect to which this Warrant shall not have been exercised shall also
be issued to the Holder within such time.

 

(h)Issue
Taxes. The issuance of certificates for shares of stock upon the exercise of the rights represented by this Warrant shall
be made without charge to the Holder for any issuance tax in respect thereof; provided, however, that the Company
shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any
certificate in a name other than that of the Holder of the Warrant.

 

(i) Conditional
Exercise. The Holder of this Warrant shall have the right to submit a notice of exercise of this Warrant conditional upon
an acquisition of the Company. If such transaction upon which such exercise is conditioned is not consummated, such notice of exercise
shall be deemed of no further force or effect. For the purposes hereof, the Fair Market Value for the purposes of Section 1(b)
hereto shall be the value of the consideration payable or issuable to the holders of the Company's Common Stock.

 

(j)Stock
Fully Paid; Reservation of Shares. All Warrant Shares that may be issued upon the exercise of the rights represented by
this Warrant, upon issuance, will be duly and validly issued, will be fully paid and nonassessable, will not violate any preemptive
rights or rights of first refusal, will be free from restrictions on transfer other than restrictions on transfer imposed by applicable
federal and state securities laws, will be issued in compliance with all applicable federal and state securities laws, and will
have the rights, preferences and privileges described in the Company's Articles of Incorporation, as amended; and the Warrant Shares
will be free of any liens or encumbrances, other than any liens or encumbrances created by or imposed upon the Holder through no
action of the Company. During the period within which the rights represented by the Warrant may be exercised, the Company will
at all times have authorized and reserved for the purpose of issuance upon exercise of the purchase rights evidenced by this Warrant,
a sufficient number of shares of Common Stock to provide for the exercise of the right represented by this Warrant.

 

    	 	-4-	 

     

    

  

		2.	Adjustment Rights.

 

(a)Right
to Adjustment. The number of Warrant Shares purchasable upon the exercise of the rights represented by this Warrant, and
the Exercise Price therefor, shall be subject to adjustment from time to time upon the occurrence of certain events, as follows:

 

(i)          Merger.
If at any time there shall be a merger, consolidation or any other transaction of the Company with another entity pursuant
to which the Company is not the surviving corporation, then, as a part of such merger or consolidation, lawful provision shall
be made so that the holder of this Warrant shall thereafter be entitled to receive Warrant of the surviving entity with substantially
equivalent terms as this Warrant, exercisable for the period specified herein. In any such case, appropriate adjustment shall be
made in the application of the provisions of this Warrant with respect to the rights and interests of the Holder after the merger
or consolidation.

 

(ii)         Stock
Splits, Dividends, Combinations and Consolidations. In the event of a stock split, stock dividend or subdivision of or
in respect of the outstanding shares of Common Stock, the number of Warrant Shares issuable upon the exercise of the rights represented
by this Warrant immediately prior to such stock split, stock dividend or subdivision shall be proportionately increased and the
Exercise Price then in effect shall be proportionately decreased, effective at the close of business on the date of such stock
split, stock dividend or subdivision, as the case may be. In the event of a reverse stock split, consolidation, combination or
other similar event of or in respect of the outstanding shares of Common Stock, the number of Warrant Shares issuable upon the
exercise of the rights represented by this Warrant immediately prior to such reverse stock split, consolidation, combination or
other similar event shall be proportionately decreased and the Exercise Price shall be proportionately increased, effective at
the close of business on the date of such reverse stock split, consolidation, combination or other similar event, as the case may
be.

 

(b)Adjustment
Notices. Upon any adjustment of the Exercise Price, and any increase or decrease in the number of Warrant Shares subject
to this Warrant, in accordance with this Section 2, the Company, within 30 days thereafter, shall give written notice thereof to
the Holder at the address of such Holder as shown on the books of the Company, which notice shall state the Exercise Price as adjusted
and, if applicable, the increased or decreased number of Warrant Shares subject to this Warrant, setting forth in reasonable detail
the method of calculation of each such adjustment.

 

		3.	Transfer of Warrant.

 

(a)Conditions.
This Warrant and the rights represented hereby may be transferred by the Holder in whole or in part. In order to effect any
transfer of all or a portion of this Warrant, the Holder hereof shall deliver to the Company a completed and duly executed Notice
of Transfer, in the form attached as Exhibit C hereto. The Company shall, upon receipt of a transfer notice and appropriate
documentation, promptly register any Transfer on the Company’s Warrant Register

 

    	 	-5-	 

     

    

  

		4.	Piggyback Registration Rights. 

 

(a)If
the Company, during the term of this Warrant, proposes to register any of its securities under the Securities Act (other than in
connection with a transaction contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to registration on Form
S-4 or any successor forms) whether for its own account or for the account of any holder or holders of its shares, the Company
shall at each such time give prompt (but not less than thirty (30) days prior to the anticipated effectiveness thereof) written
notice to the holder of this Warrant and to its assignees, if any, of its intention to do so. The holder of Warrant shall exercise
the “piggy-back” rights provided herein by giving written notice within ten (10) days after the receipt of any such
notice. Except as set forth in Section 4(ii), the Company will use reasonable commercial efforts to effect the registration under
the Securities Act of all of the Warrant Shares which the Company has been so requested to register by such holder, to the extent
required to permit the disposition of the Warrant Shares so to be registered, by inclusion of such Warrant Shares in the registration
statement which covers the securities which the Company proposes to register. The Company will pay all registration expenses in
connection with each registration of Warrant Shares pursuant to this Section 4.

 

(b)If
the Company at any time proposes to register any of its securities under the Securities Act as contemplated by this Section 4 and
such securities are to be distributed by or through one or more underwriters, the Company will, if requested by a holder of Warrant,
use its reasonable commercial efforts to arrange for such underwriters to include all the Warrant Shares to be offered and sold
by such holder among the securities to be distributed by such underwriters.

 

		5.	Registration Procedures.

 

(c)Whenever
the holders of Warrant have properly requested that any Warrant Shares be registered pursuant to the terms of this Warrant, the
Company shall effect the registration for the sale of such Warrant Shares in accordance with the intended method of disposition
thereof, and pursuant thereto the Company shall as expeditiously as possible:

 

(d)prepare
and file with the SEC a registration statement with respect to such Warrant Shares and cause such registration statement to become
effective;

 

(e)notify
such holders of the effectiveness of each registration statement filed hereunder and prepare and file with the SEC such amendments
and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to (i) keep
such registration statement effective and the prospectus included therein usable for a period commencing on the date that such
registration statement is initially declared effective by the SEC and ending on the date when all Warrant Shares covered by such
registration statement have been sold pursuant to the registration statement, and (ii) comply with the provisions of the Securities
Act with respect to the disposition of all securities covered by such registration statement during such period in accordance with
the intended methods of disposition by the sellers thereof set forth in such registration statement;

 

    	 	-6-	 

     

    

 

(f)furnish
to such holders such number of copies of such registration statement, each amendment and supplement thereto, the prospectus included
in such registration statement (including each preliminary prospectus) and such other documents as such seller may reasonably request
in order to facilitate the disposition of the Warrant Shares owned by such holders;

 

(g)register
or qualify such Warrant Shares under such other securities or blue sky laws of such jurisdictions as such holders reasonably request
and do any and all other acts and things which may be reasonably necessary or advisable to enable such holders to consummate the
disposition in such jurisdictions of the Warrant Shares owned by such holders; provided, however, that the Company shall not be
required to: (i) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for
this subparagraph; (ii) subject itself to taxation in any such jurisdiction; or (iii) consent to general service of process in
any such jurisdiction;

 

(h)notify
such holders, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening
of any event as a result of which the prospectus included in such registration statement contains an untrue statement of a material
fact or omits any material fact necessary to make the statements therein, in light of the circumstances in which they are made,
not materially misleading, and, at the reasonable request of such holders, the Company shall prepare a supplement or amendment
to such prospectus so that, as thereafter delivered to the purchasers of such Warrant Shares, such prospectus shall not contain
an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in light of
the circumstances in which they are made, not materially misleading;

 

(i)  provide
a transfer agent and registrar for all such Warrant Shares not later than the effective date of such registration statement;

 

(j)make
available for inspection by any underwriter participating in any disposition pursuant to such registration statement, and any attorney,
accountant or other agent retained by any such underwriter, all financial and other records, pertinent corporate documents and
properties of the Company, and cause the Company’s officers, directors, managers, employees and independent accountants to
supply all information reasonably requested by any such underwriter, attorney, accountant or agent in connection with such registration
statement;

 

(k)comply
with all applicable rules and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable,
an earnings statement of the Company, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities
Act and, at the option of the Company, Rule 158 thereunder;

 

(l)in
the event of the issuance of any stop order suspending the effectiveness of a registration statement, or of any order suspending
or preventing the use of any related prospectus or suspending the qualification of any Warrant Shares included in such registration
statement for sale in any jurisdiction, the Company shall use reasonable commercial efforts promptly to obtain the withdrawal of
such order; and

 

    	 	-7-	 

     

    

 

(m)if
the offering is underwritten, to furnish on the date that Warrant Shares are delivered to the underwriters for sale pursuant to
such registration, an opinion dated such date of counsel representing the Company for the purposes of such registration, addressed
to the underwriters covering such issues as are reasonably required by such underwriters.

 

		6.	No Shareholder Rights. 

 

(a)The
Holder of this Warrant (and any transferee hereof) shall not be entitled to vote on matters submitted for the approval or consent
of the shareholders of the Company or to receive dividends declared on or in respect of shares of Common Stock, or otherwise be
deemed to be the holder of Common Stock or any other capital stock or other securities of the Company which may at any time be
issuable upon the exercise of the rights represented hereby for any purpose, nor shall anything contained herein be construed to
confer upon the Holder (or any transferee hereof) any of the rights of a shareholder of the Company or any right to vote for the
election of directors or upon any matter submitted for the approval or consent of the shareholders, or to give or withhold consent
to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, merger or consolidation,
conveyance, or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until this
Warrant shall have been exercised as provided herein. No provision of this Warrant, in the absence of the actual exercise of such
Warrant or any part thereof into Common Stock issuable upon such exercise, shall give rise to any liability on the part of such
Holder as a shareholder of the Company, whether such liability shall be asserted by the Company or by creditors of the Company.

 

		7.	Miscellaneous.

 

(a)Governing
Law. This Warrant will be construed in accordance with, and governed in all respects by, the laws of the State of California,
as applied to agreements entered into, and to be performed entirely in such state, between residents of such state.

 

(b)Dispute
Resolution. 

 

(i)          Negotiation.
In the event of any dispute, controversy or claim arising out of or relating to this Warrant, representatives of the parties
will meet in a location chosen by the party initiating the negotiation not later than ten business days after written notice from
one party to the other of such dispute and will enter into good faith negotiations aimed at resolving the dispute. If they are
unable to resolve the dispute in a mutually satisfactory manner within 30 business days from the date of such notice, the matter
may be submitted by either party to arbitration as provided for in Section 5(b)(ii), below.

 

(ii)         Arbitration.

 

(a)Any
dispute, controversy or claim between or among any of the parties hereto arising out of or relating to this Warrant or the breach,
termination or invalidity thereof, including any dispute as to whether any dispute is subject to arbitration, which has not been
resolved after good faith negotiations pursuant to subsection 5(b)(i) hereof will be settled by binding arbitration administered
by the American Arbitration Association in accordance with its then current Commercial Arbitration Rules except as provided herein.

 

    	 	-8-	 

     

    

  

(b)Any
arbitration will be conducted in a location in the metropolitan area of the party responding to the action by a three person arbitration
panel. The three person arbitration panel will consist of one party arbitrator selected by the Company, one party arbitrator selected
by the Holder, each of whom will be named within ten business days of the demand for arbitration, and one neutral arbitrator selected
by the first two arbitrators. If the two party appointed arbitrators cannot agree on the neutral arbitrator within ten business
days of the selection of the last party appointed arbitrator, the American Arbitration Association will appoint the neutral arbitrator,
who will act as chairperson. In the event of a vacancy with respect to an arbitrator, the vacancy will be filled within ten business
days of notice of the vacancy in the same manner and subject to the same requirements as are provided for in the original appointment
to that position. If the vacancy is not filled within ten business days, the American Arbitration Association will make the appointment.

 

(c)It
is the intent of the parties to avoid the appearance of impropriety due to bias or partiality on the part of the neutral arbitrator.
Accordingly, prior to his or her appointment, such neutral arbitrator will disclose to the parties and the other members of the
tribunal, any financial, fiduciary, kinship or other relationship between the neutral arbitrator and any party or its counsel.
Any party will have the right to challenge in writing the appointment of the neutral arbitrator on the basis of and within five
days of such disclosure. In the event of a challenge, the American Arbitration Association will uphold or dismiss the challenge
and its decision will be conclusive.

 

(d)The
law applicable to the validity of the arbitration clause, the conduct of the arbitration, including the resort to a court for interim
relief, enforcement of the award or any other question of arbitration law or procedure will be the United States' Federal Arbitration
Act, 9 U.S.C. § 1 et seq. The parties shall be entitled to engage in reasonable discovery including requests
for the production of all relevant documents and a reasonable number of depositions. The arbitration panel shall have the sole
discretion to determine the reasonableness of any requested document production or deposition. It is the intent of the parties
that a substantive hearing be held as soon as practicable after the appointment of the neutral arbitrator or the rejection of a
challenge thereto, whichever occurs later. The presentation of evidence will be governed by the federal Rules of Evidence. A stenographic
record of all witness testimony will be made.

 

    	 	-9-	 

     

    

 

(e)Any
award, including any interim award, made will be made by a majority of the arbitrators applying the substantive law of California
and will (i) be in writing and state the arbitration panel's findings of fact and conclusions of law, (ii) be made promptly,
and in any event within 60 days after the conclusion of the arbitration hearing; and (iii) be binding against the parties
involved and may be entered for enforcement in any court of competent jurisdiction.

 

(f)Fifty
percent of the costs of any arbitration proceeding (e.g., arbitrators, court reporter and room rental fees) will be borne by the
Company with the remaining 50% to paid by the other party to the dispute. However, each party will pay its own expense, including
attorneys' and other professionals' fees and disbursements.

 

(g)The
arbitration provision set forth in this Section 5(b)(ii) will be a complete defense to any suit, action or proceeding instituted
in any court with respect to any matter arbitrable under this Warrant, except that judicial intervention may be sought in accordance
with Section 5(b)(iii) hereof.

 

(iii)        No
Waivers; Interim Relief. The parties mutually acknowledge that an award of damages may be inadequate to remedy any breach
hereof and that injunctive relief may be required. Therefore, (i) a party may request a court of competent jurisdiction to provide
interim injunctive relief in aid of arbitration or to prevent a violation of this Warrant pending arbitration, and any such request
will not be deemed a waiver or breach of the obligations to arbitrate set forth herein and (ii) the arbitrators may order equitable
relief where they deem it appropriate and the parties agree that any interim relief ordered by the arbitrators may be immediately
and specifically enforced by a court otherwise having jurisdiction over the parties.

 

(c)Successors
and Assigns. Subject to the restrictions on transfer described in Section 3, the rights and obligations of the Company
and Holder of this Warrant shall be binding upon and benefit the successors, assigns, heirs, administrators and transferees of
the parties.

 

(d)Waiver
and Amendment. Any provision of this Warrant may be amended, waived or modified upon the written consent of the Company
and the Holder.

 

(e)Notices.
All notices and other communications required or permitted hereunder will be in writing and will be sent by fax or mailed by
first-class mail, postage prepaid, or delivered either by hand or by messenger, addressed (a) if to the Holder, at the address
indicated on the Company's books, or at such other address and fax number as Holder will have furnished to the Company in writing,
or (b) if to the Company, at 633 17th Street, Suite 1700-A, Denver, Colorado 80202, Attn: Chief Executive Officer,
or at such other address and fax number as the Company will have furnished to the Holder and each such other holder in writing.

 

    	 	-10-	 

     

    

 

Each such
notice or other communication will for all purposes of this Agreement be treated as effective or having been given when delivered
if delivered personally or by messenger, or, if sent by mail, at the earlier of its receipt or 72 hours after the same has been
deposited in a regularly maintained receptacle for the deposit of the United States mail addressed and mailed as aforesaid.

 

(f)Severability.
In case any provision of this Warrant will be invalid, illegal or unenforceable, the validity, legality and enforceability of the
remaining provisions will not in any way be affected or impaired thereby.

 

(g)Lost
Warrant. Upon receipt from the Holder of written notice or other evidence reasonably satisfactory to the Company of the
loss, theft, destruction or mutilation of the Warrant and, in the case of any such loss, theft or destruction, upon receipt of
an unsecured indemnity agreement and an affidavit of lost warrant, or in the case of any such mutilation upon surrender and cancellation
of the Warrant, the Company, at the Company's expense, will make and deliver a new Warrant in lieu of the lost, stolen, destroyed
or mutilated Warrant carrying the same rights and obligations as the original Warrant. The Company will also pay the cost of all
deliveries of the Warrant upon any exchange thereof.

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer as of the date first written
above.

 

	 	KEY LINK ASSETS CORP.
	 	a Delaware corporation
	 	 	 
	 	By:	 
	 	 	B.P. Allaire
	 	 	 
	 	Its:	Chief Executive Officer

 

    	 	-11-	 

     

    

 

EXHIBIT A

 

NOTICE OF CASH EXERCISE

 

TO:___________________________

 

1.           The undersigned
hereby elects to purchase ________________ shares of Common Stock of Key Link Assets Corp., a Delaware corporation (the “Company”),
pursuant to the terms of Warrant No. issued May , 2016, to and in the name of Zhuge Liang LLC, a copy of which is attached hereto
(the “Warrant”), and tenders herewith full payment of the aggregate Exercise Price for such shares in accordance with
the terms of the Warrant.

 

2.           Please issue
a certificate or certificates representing said shares of ____________ Stock in such name or names as specified below:

 

	 	 	 
	(Name)	 	(Name)
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	(Address)	 	(Address)

 

The undersigned hereby
represents and warrants that the aforesaid shares of stock are being acquired for the account of the undersigned for investment
and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned has no present intention
of distributing or reselling such shares.

 

	Date:	 	 	By:	 	 

 

	 	 	 	Print Name:	 	 

 

	 	(Signature must conform in all respects to name of the Holder as set forth on the face of the Warrant)

 

    	 	-12-	 

     

    

 

EXHIBIT B

 

NOTICE OF NET-ISSUE EXERCISE

 

TO:[_________]

 

1.           The undersigned
hereby elects to purchase ____________ shares of common stock of Key Link Assets Corp., a Delaware corporation, (the “Company”),
on a cashless basis pursuant to the terms of Warrant No. issued May , 2016, to and in the name of Zhuge Liang LLC, a copy of which
is attached hereto (the “Warrant”).

 

2.           Cashless Information:

 

(a)           Number
of shares of common stock to be delivered:___________

 

(b)           Number
of Share of Common Stock Subject to the Warrant Surrendered:________________

 

(c)           Number
of Shares of Common Stock Remaining Subject to Warrant:_______________

 

3.Please issue
a certificate or certificates representing said shares of common stock in such name or names as specified below:

 

 

	 	 	 
	(Name)	 	(Name)
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	(Address)	 	(Address)

 

	Date:	 	 	 	 
	 	 	 	Print Name	 

 

	 	 	 	By:	 

 

 

(Signature must conform in all respects
to name of the Holder as set forth on the face of the Warrant)

 

    	 	 	 

     

    

 

EXHIBIT C

 

NOTICE OF TRANSFER

 

FOR VALUE RECEIVED,
the undersigned hereby sells, assigns and transfers unto ______________________________ the right represented by Warrant No. issued
on May , 2016, to and in the name of __________________________, to purchase ________ shares of Common Stock of Key Link Assets
Corp, a Delaware corporation (the “Company”), a copy of which is attached hereto (the “Warrant”), and appoints
______________________________ as attorney-in-fact to transfer such right on the books of the Company with full power of substitution
in the premises.

 

	Date:	 	 	Name.	 
	 	 	 	 	 
	 	 	 	By:	 
	 	 	 	 	(Signature must conform in all respects to name of the Holder as set forth on the face of the Warrant)
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	(Address)

 

	Signed in the presence of:EX-10.1

 Exhibit 10.1 

VOTING AGREEMENT 

THIS VOTING AGREEMENT (this “Agreement”) dated August 15, 2016, is entered into among StemCells,
Inc., a Delaware Corporation (“Parent”), each of the stockholders listed on Schedule I to this Agreement (each a “Stockholder” and collectively, the “Stockholders”), and
Microbot Medical Ltd., a company organized under the laws of the State of Israel (“Company”). 
 W I T N E S S
E T H: 
 WHEREAS, Parent, C&RD Israel Ltd., an Israeli corporation and wholly-owned subsidiary of Parent
(“Merger Sub”), and the Company have entered into an Agreement and Plan of Merger and Reorganization, dated as of August 15, 2016 (as it may be amended or supplemented from time to time, the “Merger
Agreement”), pursuant to which and upon the terms and subject to the conditions thereof, Merger Sub will be merged with and into the Company, and the Company will be the surviving entity (the “Merger”); 

WHEREAS, as of the date hereof, each Stockholder is the record and beneficial owner of the number of shares (the
“Shares”) of Company Stock, set forth opposite such Stockholder’s name on Schedule I attached hereto (such Shares, together with any other shares of capital stock of the Company acquired by such Stockholder after the
date hereof and during the term of this Agreement (including through the exercise of any stock options, warrants or any other convertible or exchangeable securities or similar instruments), being collectively referred to herein as such
Stockholder’s “Subject Shares”); 
 WHEREAS, as a condition to the consummation of the Merger, and in
order to induce Parent to enter into the Merger Agreement and consummate the Merger, Parent has required that each Stockholder agree, and each Stockholder is willing to agree, to the matters set forth herein; 

NOW, THEREFORE, in contemplation of the foregoing and in consideration of the mutual agreements, covenants, representations and
warranties contained herein and intending to be legally bound hereby, Parent, on the one hand, and each Stockholder, severally and not jointly, on the other hand, agree as follows: 

Section 1. Defined Terms. Capitalized terms used but not defined herein have the meanings set forth in the Merger Agreement.

 Section 2. Voting of Shares. 

(a) Voting. Until this Agreement or the Merger Agreement is terminated in accordance with its terms, Stockholder hereby
agrees to vote (or cause to be voted) all of Stockholder’s Subject Shares, at every annual, special or other meeting of the stockholders of the Company, and at any adjournment or adjournments thereof, or pursuant to any consent in lieu of a
meeting or otherwise: 
 (i) in favor of the Merger and the adoption of the Merger Agreement and the approval of the transactions
contemplated by the Merger Agreement, and any actions required in furtherance thereof; 

 (ii) against any action or agreement that would result in a breach in any material respect of
any covenant, representation or warranty or any other obligation of the Company under the Merger Agreement; and 
 (iii) against
(A) any Acquisition Proposal involving the Company or any of its subsidiaries, or (B) any action that is intended, or would reasonably be expected, to impede, interfere with, prevent, delay, postpone or adversely affect the Merger or the
transactions contemplated by the Merger Agreement. 
 Prior to the termination of this Agreement, Stockholder shall not enter into any agreement,
understanding or arrangement (whether written or oral) with any Person to vote or give instructions in any manner inconsistent with clauses “(i)”, “(ii)” or “(iii)” of this Section 2(a). 

(b) Grant of Irrevocable Proxy.

(i) Contemporaneously with the execution of this Agreement: (i) Stockholder shall deliver to Parent a proxy in the form attached hereto
as Exhibit A, which shall be irrevocable to the fullest extent permitted by law with respect to the securities referred to therein (the “Proxy”); and (ii) if applicable, Stockholder shall cause to be delivered to
Parent an additional proxy (in the form attached hereto as Exhibit A) executed on behalf of the record owner of any outstanding Subject Shares that are owned beneficially (within the meaning of Rule 13d-3 under the Exchange Act) but not of record by
Stockholder. 
 (ii) Stockholder shall not enter into any tender, voting or other agreement, understanding or arrangement, or grant a proxy
or power of attorney with respect to Stockholder’s Subject Shares that is inconsistent with this Agreement or otherwise take any other action with respect to Stockholder’s Subject Shares that would in any way restrict, limit or interfere
with the performance of the Stockholder’s obligations hereunder or the transactions contemplated hereby or under any proxy delivered to Parent by Stockholder or on Stockholder’s behalf. 

Section 3. Fiduciary Responsibilities. If Stockholder (or an affiliate or designee of Stockholder) is or becomes during the
term hereof a director or officer of the Company, Stockholder does not make (or shall not be deemed to have made) any agreement or understanding herein in such person’s capacity as such director or officer of the Company. Without limiting the
generality of the foregoing, Stockholder signs solely in his, her or its capacity as the record and beneficial owner of Stockholder’s Subject Shares and nothing herein shall limit or affect any actions taken by Stockholder (or an affiliate or
designee of Stockholder) in his or her capacity as an officer or director of the Company in exercising his or her or the Company’s or the Company’s board of directors’ rights in connection with the Merger Agreement or otherwise and
such actions shall not be deemed to be a breach of this Agreement. 

 Section 4. Representations and Warranties of Stockholder. Stockholder represents
and warrants to Parent as follows: 
 (a) Binding Agreement. Stockholder has the capacity to execute and deliver this Agreement
and to consummate the transactions contemplated hereby. Stockholder has duly and validly executed and delivered this Agreement and, assuming the due authorization, execution and delivery of this Agreement by Parent, this Agreement constitutes a
legal, valid and binding obligation of Stockholder, enforceable against Stockholder in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or other similar laws affecting
creditors’ rights generally and by general equitable principles (regardless of whether enforceability is considered in a proceeding in equity or at law). 

(b) No Conflict. Neither the execution and delivery of this Agreement by Stockholder, nor the performance by Stockholder of
its obligations hereunder will (i) require any consent, approval, authorization or permit of, registration, declaration or filing (except for such filings as may be required under the federal securities laws or as would not prevent, delay or
otherwise impair Stockholder’s ability to perform its obligations hereunder) with, or notification to, any Government Authority, (ii) if Stockholder is an entity, result in a violation of, or default under, or conflict with any provision
of its certificate of incorporation, bylaws, partnership agreement, limited liability company agreement or similar organizational documents, (iii) result in a violation or breach of, or constitute (with or without due notice or lapse of time or
both) a default (or give rise to any right of termination, cancellation, or acceleration) under any contract, trust, agreement, instrument, commitment, arrangement or understanding applicable to Stockholder or Stockholder’s Subject Shares, or
result in the creation of a security interest, lien, charge, encumbrance, equity or claim with respect to any of Stockholder’s Subject Shares, except, in the case of clause (iii), as would not prevent, delay or otherwise impair
Stockholder’s ability to perform its obligations hereunder, (iv) require any consent, authorization or approval of any Person other than a Government Authority, except, in the case of clause (iv), as would not prevent, delay or
otherwise impair Stockholder’s ability to perform its obligations hereunder or (v) violate or conflict with any order, writ, injunction, decree, rule, regulation or law applicable to Stockholder or Stockholder’s Subject
Shares. If Stockholder is a married individual and Stockholder’s Subject Shares constitute community property or otherwise need spousal approval in order for this Agreement to be a legal, valid and binding obligation of Stockholder, this
Agreement has been duly authorized, executed and delivered by, and constitutes a legal, valid and binding obligation of, Stockholder’s spouse, enforceable against such spouse in accordance with its terms, except as such enforceability may be
limited by applicable bankruptcy, insolvency, reorganization or other similar laws affecting creditors’ rights generally and by general equitable principles (regardless of whether enforceability is considered in a proceeding in equity or at
law). 
 (c) Ownership of Shares. Stockholder is the record and beneficial owner of the Shares and options, warrants and any
additional rights to acquire Shares set forth opposite Stockholder’s name on Schedule I attached hereto free and clear of any security interests, liens, charges, encumbrances, equities, claims, options or limitations of whatever nature and
free of any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose of such Shares), except for any such encumbrances arising hereunder. Other than as set forth on Schedule I, as of the date of this
Agreement, Stockholder does not own (beneficially or otherwise) any shares of Company Stock or any options, warrants, notes or other rights to acquire shares of Company Stock. No Person has any right to acquire from Stockholder any of the securities
set forth on Schedule I and Stockholder has no obligation to sell or dispose of any 

 
such securities. Except for the rights granted to Parent under this Agreement, Stockholder holds exclusive power to vote the Shares set forth opposite Stockholder’s name on Schedule I
attached hereto.
 (d) Broker Fees. No broker, investment banker, financial advisor or other person is entitled to any
broker’s, finder’s, financial advisor’s or other similar fee or commission based upon arrangements made by or on behalf of Stockholder in connection with its entering into this Agreement. 

(e) Accuracy of Representations. The representations and warranties contained in this Agreement are accurate in all respects as of
the date hereof and will be accurate in all respects at all times prior to the termination of this Agreement as if made on and as of any such time or date.

Section 5. Transfer and Other Restrictions. Until this Agreement is terminated in accordance with its terms: 

(a) Certain Prohibited Transfers. Stockholder agrees not to (directly or indirectly): 

(i) (A) sell, transfer, pledge, encumber, assign, make any short sale of, or enter into any hedging or similar transaction having the same
economic effect as a sale, or otherwise dispose of Stockholder’s Subject Shares or any interest contained therein, or (B) enter into any contract, option or other arrangement or understanding with respect to any matter referred to in
clause “(A)” relating to the Stockholder’s Subject Shares or any interest contained therein (each of the matters in clauses “(A)” and “(B”) collectively referred to herein as a
“Transfer”); 
 (ii) grant any proxies or powers of attorney or enter into a voting agreement or
other arrangement with respect to Stockholder’s Subject Shares, other than this Agreement; 
 (iii) enter into, or deposit
Stockholder’s Subject Shares into, a voting trust or take any other action which would, or could reasonably be expected to, result in a diminution of the voting power represented by any of Stockholder’s Subject Shares; or 

(iv) commit or agree to take any of the foregoing actions. 

(b) Permitted Transfers. Section 5(a) hereof shall not prohibit a Transfer of Subject Shares by Stockholder (any such Transfer, a
“Permitted Transfer”): (i) if Stockholder is an individual: (A) to any member of Stockholder’s immediate family; or to a trust or other estate planning vehicle for the benefit of Stockholder or any member of
Stockholder’s immediate family; or (B) upon the death of Stockholder to Stockholder’s heirs; (ii) if Stockholder is a partnership or limited liability company, to one or more partners or members of Stockholder or to an affiliated
corporation, trust or other business entity under common control with Stockholder, or if Stockholder is a trust, to a beneficiary; or (iii) to another holder of the capital stock of the Company that has signed a voting agreement in
substantially the form hereof; provided however, that a Transfer referred to on this Section 5(b) shall be permitted only if, as a 

 
precondition to such Transfer, the transferee agrees in writing, reasonably satisfactory in form and substance to Parent, to be bound by all of the terms of this Agreement and provides a Proxy as
required by Section 2(b) hereof. 
 (c) Efforts. Stockholder agrees not to take any action which would make any
representation or warranty of Stockholder herein untrue or incorrect in any material respect as of any time prior to the termination hereof or take any action that would have the effect of preventing or disabling it from performing its obligations
under this Agreement. Subject to Section 3 hereof, until this Agreement is terminated in accordance with its terms, Stockholder shall use its reasonable best efforts to take, or cause to be taken, all actions reasonably necessary or
desirable to vote (or cause to be voted) all of Stockholder’s Subject Shares in accordance with Section 2(a) of this Agreement (including executing and delivering additional documents as Parent may request, at the cost and expense of
Parent). 
 (d) Additional Shares. In the event (i) of any stock dividend, stock split, recapitalization, reclassification,
combination or exchange of shares of capital stock of the Company on, of or affecting Stockholder’s Subject Shares or (ii) Stockholder becomes the beneficial owner of any additional shares of Company Stock or other securities entitling the
holder thereof to vote or give consent with respect to the matters set forth in Section 2(a) hereof, then the terms of this Agreement shall apply to the shares of capital stock or other securities of the Company held by Stockholder immediately
following the effectiveness of the events described in clause (i) or Stockholder becoming the beneficial owner thereof, as described in clause (ii), as though they were Stockholder’s Subject Shares hereunder. Stockholder hereby
agrees, until this Agreement is terminated in accordance with its terms, to notify Parent of the number of any new shares of Company Stock acquired by Stockholder, if any, after the date hereof. 

Section 6. Appraisal Rights. Stockholder hereby agrees not to exercise any appraisal rights or any dissenters’ rights that
Stockholder may have (whether under applicable law or otherwise) or could potentially have or acquire in connection with the Merger Agreement, and the transactions contemplated by the Merger Agreement, including the Merger. 

Section 7. No Solicitation. Until this Agreement is terminated in accordance with its terms, Stockholder shall not, nor shall
Stockholder permit any investment banker, attorney or other advisor or representative of the Stockholder to, directly or indirectly through another Person, take any action that the Company is prohibited from taking or authorizing to be taken
pursuant to Section 5.3 of the Merger Agreement; provided, however, that any action which is permitted by the Merger Agreement to be taken by Stockholder (or an affiliate or designee of Stockholder) in his or her capacity as a
director or officer of the Company or which is permitted by Section 3 hereof shall not be prohibited by the foregoing so long as such action is taken by Stockholder (or such affiliate or designee) in his or her actual capacity as a director or
officer of the Company. 
 Section 8. Specific Enforcement; Jurisdiction. Stockholder agrees that irreparable damage would occur
in the event that any of the provisions of this Agreement or the Proxy were not performed in accordance with the terms hereof or were otherwise breached and that Parent shall be entitled to specific performance of the terms hereof in addition to any
other 

 
remedy which may be available at law or in equity. It is accordingly agreed that Parent will be entitled to an injunction or injunctions to prevent breaches of this Agreement or the Proxy and to
enforce specifically the terms and provisions of this Agreement or the Proxy in any state or federal court located in the State of Delaware or in the Court of Chancery of the State of Delaware, the foregoing being in addition to any other remedy to
which they are entitled at law or in equity. In addition, each of Stockholder and Parent hereto (a) consents to submit itself to the personal jurisdiction of any state or federal court located in the State of Delaware or in the Court of
Chancery of the State of Delaware in the event any dispute arises out of this Agreement or any of the transactions contemplated by this Agreement or the Proxy, (b) agrees that it will not attempt to deny or defeat such personal jurisdiction by
motion or other request for leave from any such court, and (c) agrees that it will not bring any action relating to this Agreement or the Proxy or any of the transactions contemplated by this Agreement in any court other than a state or federal
court located in the State of Delaware or the Court of Chancery of the State of Delaware. 
 Section 9. Termination. This
Agreement shall terminate and cease to have any force or effect on the earliest of (a) the termination of the Merger Agreement in accordance with its terms, (b) the written agreement of Parent and Stockholder to terminate this Agreement,
(c) the consummation of the Merger, and (d) the amendment, modification or waiver of the Merger Agreement to alter the Merger Consideration in a manner adverse to Stockholder unless such amendment, modification or waiver has been consented
to by Stockholder in writing prior to or simultaneously with such amendment, modification or waiver; provided, however, that (i) Sections 8 through 19 shall survive any termination of this Agreement and (ii) termination
of this Agreement shall not relieve any party from liability for any breach of its obligations hereunder committed prior to such termination. 

Section 10. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly
given if delivered personally, mailed by certified mail (return receipt requested) or sent by overnight carrier or by facsimile (upon confirmation of receipt) to the parties at the following addresses or at such other as shall be specified by the
parties by like notice: (a) if to Parent, to the appropriate address set forth in Section 9.4 of the Merger Agreement (with a copy to Ropes & Gray LLP); (b) if to the Company, to the appropriate address set forth in
Section 9.4 of the Merger Agreement (with a copy to each of Ruskin Moscou Faltischek, P.C. and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.), and (c) if to Stockholder, to the appropriate address set forth on Schedule I hereto.

Section 11. Stockholder Information. Stockholder agrees to permit Parent to publish and disclose in the Proxy Statement and any
other public disclosure that Parent and the Company mutually determine to be necessary and desirable in connection with the Merger and any of the other transactions contemplated by the Merger Agreement the identity of Stockholder and the ownership
of securities of the Company or Parent and the nature of Stockholder’s commitments, arrangements and understandings under this Agreement and the Proxy. Parent shall provide drafts of such disclosures to be made in the Proxy Statement and such
other public disclosures to Stockholder reasonably in advance of such disclosures and shall consider in good faith any comments provided by Stockholder in a timely manner. 

 Section 12. Certain Events. Stockholder agrees that this Agreement and the
obligations hereunder shall attach to Stockholder’s Subject Shares and shall be binding upon any person or entity to which legal or beneficial ownership of Stockholder’s Subject Shares shall pass, whether by operation of law or otherwise,
including Stockholder’s heirs, guardians, administrators or successors. 
 Section 13. Entire Agreement. This Agreement
(including the documents and instruments referred to herein) constitutes the entire agreement and supersedes all other prior agreements and understandings, both written and oral, among the parties, or any of them, with respect to the subject matter
hereof. 
 Section 14. Amendment. This Agreement may not be modified, amended, altered or supplemented except upon the execution
and delivery of a written agreement executed by Parent and Stockholder. 
 Section 15. Successors and Assigns. Neither this
Agreement nor any rights or obligations hereunder shall be assigned (by operation of law or otherwise) or delegated to any Person without the prior written consent of the other parties hereto and any attempted assignment or delegation thereof shall
be void ab initio. This Agreement will be binding upon, inure to the benefit of and be enforceable by each party and such party’s heirs, beneficiaries, executors, successors, representatives and permitted assigns. Nothing in this
Agreement is intended to confer on any Person (other than the parties hereto and their successors and permitted assigns) any rights or remedies of any nature. 

Section 16. Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in separate
counterparts, and delivered by means of facsimile transmission, electronic delivery or otherwise, each of which when so executed and delivered shall be deemed to be an original and all of which when taken together shall constitute one and the same
agreement and shall be sufficient to bind the parties hereto to the terms and conditions of this Agreement. 
 Section 17. GOVERNING
LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE REGARDLESS OF THE LAWS THAT MIGHT OTHERWISE GOVERN UNDER APPLICABLE PRINCIPLES OF CONFLICTS OF LAW THEREOF. 

Section 18. Waiver. Subject to the remainder of this Section 18, at any time prior to the termination of this Agreement, any party
hereto may: (i) extend the time for performance of any of the obligations or other acts of the other parties to this Agreement; (ii) waive any inaccuracy in or breach of any representation, warranty, covenant or obligation of the other
party to this Agreement or in any document (including the Proxy) delivered pursuant to this Agreement; and (iii) waive compliance with any covenant, obligation or condition for the benefit of such party contained in this Agreement. No failure
on the part of any party to exercise any power, right, privilege or remedy under this Agreement shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy
shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. No party shall be deemed to have waived any power, right, privilege or remedy 

 
available to such party arising out of this Agreement, unless such waiver is expressly set forth in a written instrument duly executed and delivered by the party waiving such power, right,
privilege or remedy; and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. 

Section 19. Severability. If any provision of this Agreement shall be held to be illegal, invalid or unenforceable under any
applicable law, then such contravention or invalidity shall not invalidate the entire Agreement. Such provision shall be deemed to be modified to the extent necessary to render it legal, valid and enforceable, and if no such modification shall
render it legal, valid and enforceable, then this Agreement shall be construed as if not containing the provision held to be invalid, and the rights and obligations of the parties shall be construed and enforced accordingly. 

Section 20. Several Obligations. Notwithstanding anything to the contrary in this Agreement, the obligations of each Stockholder
who is a signatory to this Agreement are several and not joint. In no event shall any Stockholder who is a signatory to this Agreement have any liability or obligation with respect to the acts or omissions of any other Stockholder who is also a
signatory to this Agreement. 
 Section 21. Headings. The headings contained in this Agreement are for reference purposes only
and shall not affect in any way the meaning or interpretation of this Agreement. 
 Section 22. Other Agreements. Contemporaneously
with the execution of this Agreement, Parent and Company are entering into agreements with certain other holders of Company Stock on the same terms as this Agreement (the “Other Voting Agreements”). Neither Parent nor the
Company shall enter into any amendment or modification of, or grant any waiver under, any Other Voting Agreement, unless the same amendment or modification of, or grant of waiver under, this Agreement is offered to Stockholder. 

[The remainder of this page is intentionally blank.] 

 IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be signed,
individually or by its respective officer thereunto duly authorized, as of the date first written above. 
  

			
	STEMCELLS, INC.
		
	By:	 	  

		 	Name:
		 	Title:
	
	STOCKHOLDER: 
		
	By:	 	  

		 	Name:
		 	Title:

 IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be signed,
individually or by its respective officer thereunto duly authorized, as of the date first written above. 
  

			
	MICROBOT MEDICAL LTD.:
		
	By:	 	  

		 	Name:
		 	Title:

 SCHEDULE I TO 

VOTING AGREEMENT 
  

									
	 Name
	  	 Address
	  	Shares of Company
Preferred Stock	  	Shares of Company
Common Stock	  	 Options to Purchase

Company Common Stock

	Life Science Accelerator Ltd.	  	 c/o Microbot Medical Ltd.
 5 Hamada St.

Yokneam 2069204, Israel
	  	-0-	  	1,833,000	  	—
	Professor Moshe Shoham	  	 c/o Microbot Medical Ltd.
 5 Hamada St.

Yokneam 2069204, Israel
	  	-0-	  	636,540	  	244,700 options to purchase Company Common Stock
	MEDX Ventures Group LLC	  	 c/o Microbot Medical Ltd.
 5 Hamada St.

Yokneam 2069204, Israel
	  	-0-	  	916,650	  	403,592 options to purchase Company Common Stock
	Leon Lewkowicz	  	 c/o Microbot Medical Ltd.
 5 Hamada St.

Yokneam 2069204, Israel
	  	754,000	  	-0-	  	 154,000 warrants to purchase Company Preferred Stock
  

139,586 shares underlying outstanding convertible promissory notes; such amount to change based on final accrued interest through the actual conversion
date.

 EXHIBIT A 

FORM OF IRREVOCABLE PROXY 

 IRREVOCABLE PROXY 

Each undersigned stockholder (each a “Stockholder”) of Microbot Medical Ltd., a company organized under the laws of
the State of Israel (the “Company”), severally and not jointly, hereby irrevocably (to the fullest extent permitted by law) appoints and constitutes StemCells, Inc., a Delaware corporation (“Parent”)
and Kenneth Stratton, solely in its capacity as an executive officer of Parent, and each of them, the attorneys and proxies of the Stockholder, with full power of substitution and resubstitution, to the full extent of Stockholder’s rights with
respect to the outstanding shares of capital stock of the Company owned of record by the Stockholder as of the date of this proxy, which shares are specified on the final page of this proxy. (The shares of the capital stock of the Company referred
to in the immediately preceding sentence are referred to as the “Shares.”) Upon the execution of this proxy, all prior proxies given by Stockholder with respect to any of the Shares are hereby revoked, and Stockholder agrees
that no subsequent proxies inconsistent with this Proxy will be given with respect to any of the Shares. 
 This proxy is irrevocable, is
coupled with an interest and is granted in connection with, and as security for, the Voting Agreement, dated as of the date hereof, between Parent, Stockholder and the Company (the “Voting Agreement”), and is granted in
consideration of and as an inducement to Parent entering into the Agreement and Plan of Merger and Reorganization, dated as of the date hereof, among Parent, C&RD Israel Ltd., Delaware corporation and wholly-owned subsidiary of Parent
(“Merger Sub”), and the Company (the “Merger Agreement”), whereby Merger Sub will be merged with and into the Company (the “Merger”). This proxy will terminate on the
termination of the Voting Agreement in accordance with its terms.
 Prior to the termination of the Voting Agreement or the Merger
Agreement, the attorneys and proxies named above will be empowered, and may exercise this proxy, to vote any Shares owned by Stockholder, at any meeting of the stockholders of the Company, however called, or at any adjournment or postponement
thereof and on every action or approval by written consent of the stockholders of the Company: 
 (i) in favor of the Merger and the
adoption of the Merger Agreement and the approval of the transactions contemplated by the Merger Agreement, and any actions required in furtherance thereof; 

(ii) against any action or agreement that would result in a breach in any material respect of any covenant, representation or warranty or any
other obligation of the Company under the Merger Agreement; and 
 (iii) against (a) any Acquisition Proposal (as defined in the
Merger Agreement) involving the Company or any of its subsidiaries, or (b) any action that is intended, or would reasonably be expected, to impede, interfere with, prevent, delay, postpone or adversely affect the Merger or the transactions
contemplated by the Merger Agreement.
 Stockholder may vote the Shares on all other matters not referred to in this proxy, and the
attorneys and proxies named above may not exercise this proxy with respect to such other matters. 

 This proxy shall be binding upon the heirs, estate, executors, personal representatives,
successors and assigns of the Stockholder (including any transferee of any of the Shares). 
 Any term or provision of this proxy that is
invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this proxy or the validity or enforceability of the offending term or provision in any other
situation or in any other jurisdiction. Upon such determination that any term or provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this proxy so as to effect the original intent
of the parties as closely as possible in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the fullest extent possible.

[Signature page follows] 

							
	Dated: August [●], 2016	 		 		 	STOCKHOLDER
				
		 		 		 	  

		 		 		 	Signature
				
		 		 		 	  

		 		 		 	Printed Name
				
		 		 		 	Number of shares of capital stock of Company owned of record as of the date of this proxy:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]